Redcare Pharmacy rises after Q2 adjusted EBITDA beats forecasts

Redcare Pharmacy NV

29/07/2025 07:42

** Shares in pharmacy retailer Redcare Pharmacy RDC.DE rise 4.5% in early Frankfurt trade after the company reported Q2 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) above forecasts

** Brokerage Metzler Research points to EBITDA being 14% above street forecasts

** It adds that a higher selling & distribution expense was almost entirely offset by pricing, better purchasing conditions, scale and positive country mix effects

** The company also reported an EBITDA margin of 2.6%, a 12 month high

** Up to the previous session's close, shares were down 19.6%​ YTD

 (Reporting by Cian Muenster)

 ((Cian.muenster@thomsonreuters.com))